Ph2 readouts in Q1 2024...

$Pfizer (PFE.US)$ Phase 2
$Leap Therapeutics (LPTX.US)$ Phase 2
$Vera Therapeutics (VERA.US)$ Phase 2b
$4D Molecular Therapeutics (FDMT.US)$ Phase 2
$Adverum Biotechnologies (ADVM.US)$ Phase 2
$Denali Therapeutics (DNLI.US)$ Phase 2
$Akero Therapeutics (AKRO.US)$ Phase 2b
$Spruce Biosciences (SPRB.US)$ Phase 2
$Xencor (XNCR.US)$ Phase 2
$Alnylam Pharmaceuticals (ALNY.US)$ Phase 2
$Harmony Biosciences (HRMY.US)$ Phase 2
$Annexon (ANNX.US)$ Phase 2a
$Roivant Sciences (ROIV.US)$ Phase 2
$TFF Pharmaceuticals (TFFP.US)$ Phase 2
$Cogent Biosciences (COGT.US)$ Phase 2
$Ironwood Pharmaceuticals (IRWD.US)$ Phase 2
$TFF Pharmaceuticals (TFFP.US)$ Phase 2
$Fusion Pharmaceuticals (FUSN.US)$ Phase 2
$Amgen (AMGN.US)$ Phase 2
$Tarsus Pharmaceuticals (TARS.US)$ Phase 2a
$Aslan Pharmaceuticals (ASLN.US)$ Phase 2
$MoonLake Immunotherapeutics (MLTX.US)$ Phase 2
$Clene (CLNN.US)$ Phase 2
$Altimmune (ALT.US)$ Phase 2
$Spruce Biosciences (SPRB.US)$ Phase 2
$Ironwood Pharmaceuticals (IRWD.US)$ Phase 2a
$Tarsus Pharmaceuticals (TARS.US)$ Phase 2a
$G1 Therapeutics (GTHX.US)$ Phase 2
$Leap Therapeutics (LPTX.US)$ Phase 2a
$Sagimet Biosciences (SGMT.US)$ Phase 2b
$Inventiva (IVA.US)$ Phase 2a
$Larimar Therapeutics (LRMR.US)$ Phase 2
$AC Immune (ACIU.US)$ Phase 2
$Innate Pharma (IPHA.US)$ Phase 2
$Intensity Therapeutics (INTS.US)$ Phase 2
$ATAI Life Sciences (ATAI.US)$ Phase 2